Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy

被引：0

作者：

Ghaly, Simon ^{[1
,2
]}

Gill, Raghubinder S. ^{[3
]}

Keegan, Mathew J. ^{[3
]}

Angus, Peter W. ^{[4
]}

George, Jacob ^{[5
,6
]}

Nicoll, Amanda J. ^{[7
]}

Law, Matthew ^{[8
]}

Sinclair, Marie ^{[9
]}

Lim, Lucy Y. ^{[4
]}

Ratnayake, Hasanka ^{[7
]}

Dunn, Anna ^{[7
]}

Strasser, Simone I. ^{[3
]}

Zekry, Amany ^{[1
,2
]}

机构：

[1] St George Hosp, Sydney, NSW, Australia

[2] St George Hosp, Sydney, NSW, Australia

[3] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia

[4] Austin Hosp, Gastroenterol & Liver Transplant Unit, Melbourne, Vic 3084, Australia

[5] Westmead Hosp, Millennium Inst, Storr Liver Unit, Sydney, NSW, Australia

[6] Univ Sydney, Sydney, NSW 2006, Australia

[7] Royal Melbourne Hosp, Melbourne, Vic, Australia

[8] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia

[9] Monash Med Ctr, Melbourne, Vic, Australia

来源：

HEPATOLOGY | 2012年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

332

引用

下载

页码：354A / 354A

页数：1

共 50 条

[31] Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B
Nam, J. Y.
Chang, Y.
Cho, H.
Kang, S. H.
Cho, Y. Y.
Cho, E. J.
Lee, J-H
Yu, S. J.
Yoon, J-H
Kim, Y. J.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 552 - 560
[32] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC VIRAL HEPATITIS
Kane, Lara J.
Macdonald, Graeme A.
CANCER FORUM, 2009, 33 (02)
[33] Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy
Fan, Rong
Niu, Junqi
Ma, Hong
Xie, Qing
Cheng, Jun
Rao, Huiying
Dou, Xiaoguang
Xie, Jianping
Zhao, Wei
Peng, Jie
Gao, Zhiliang
Gao, Hongbo
Chen, Xinyue
Chen, Jinjun
Li, Qiang
Tang, Hong
Zhang, Zhengang
Ren, Hong
Cheng, Mingliang
Liang, Xieer
Zhu, Chaonan
Wei, Lai
Jia, Jidong
Sun, Jian
Hou, Jinlin
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (03) : 329 - 338
[34] The Predictive Values of Hepatocellular Carcinoma Risk Scores are not Affected from the Antiviral Therapy in Patients with Chronic Hepatitis B Infection
Akarca, Ulus S.
Gunsar, Fulya
Turan, Ilker
Ersoz, Galip
Karasu, Zeki
Ozutemiz, Omer
HEPATOLOGY, 2015, 62 : 336A - 337A
[35] ASSOCIATION BETWEEN SERUM HBV RNA AND RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS UNDER ANTIVIRAL THERAPY
Liu, Shi
Deng, Rui
Zhou, Bin
Liang, Xieer
Liu, Zhihong
Peng, Jie
Chen, Jinjun
Zhou, Yuanping
Guo, Yabing
Chen, Yongpeng
Li, Wanying
Shen, Sheng
Lu, Xingyu
Zhao, Siru
Liao, Xingmei
Liang, Hongyan
Lan, Yu
Hou, Jinlin
Fan, Rong
Sun, Jian
HEPATOLOGY, 2021, 74 : 429A - 429A
[36] Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis
Stournaras, Evangelos
Neokosmidis, Georgios
Stogiannou, Dimitrios
Protopapas, Andreas
Tziomalos, Konstantinos
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (11) : 1277 - 1282
[37] Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?
Thursz, Mark
Brown, Ashley
GUT, 2011, 60 (08) : 1025 - 1026
[38] Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?
Warner, Nadia
Locarnini, Stephen
ANTIVIRAL THERAPY, 2009, 14 (02) : 139 - 142
[39] Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma
Wei, Qiang
Xu, Xiao
Ling, Qi
Zhou, Bo
Zheng, Shu-Sen
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2013, 12 (03) : 251 - 255
[40] Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma
Qiang Wei
Xiao Xu
Qi Ling
Bo Zhou
Shu-Sen Zheng
Hepatobiliary & Pancreatic Diseases International, 2013, 12 (03) : 251 - 255

← 1 2 3 4 5 →